FDA panel recommends Medtronic spinal implant

Wed, 07/28/2010 - 10:45am
The Associated Press

A Food and Drug Administration advisory panel has recommended clearance for Medtronic's spin implant Amplify.

The FDA's Orthopedic and Rehabilitation Devices Panel vote 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients. The FDA normally follows the advice of its panels, though it is not a requirement.

Medtronic makes a range of medical devices, including pacemakers, implantable defibrillators, and spinal implants.

Shares of Medtronic Inc., based in Minneapolis, fell 46 cents to $36.93 in afternoon trading on Wednesday.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.